| |
| |
|
| Insider
Information: |
Murphy Andrew J |
| Relationship: |
EVP Research |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
48,306 |
|
|
Indirect Shares
|
4,310 |
|
|
| Direct
Value |
$47,009,467 |
|
|
|
Indirect Value
|
$4,194,320 |
|
|
| Total
Shares |
52,616 |
|
|
| Total
Value |
$51,203,787 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Research |
2024-03-14 |
48,306 |
2024-03-14 |
4,310 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-05 |
4 |
AS |
$810.38 |
$5,342,787 |
D/D |
(6,536) |
59,421 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-11-17 |
4 |
AS |
$536.68 |
$3,597,188 |
D/D |
(6,628) |
47,136 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-13 |
4 |
D |
$623.98 |
$4,175,050 |
D/D |
(6,691) |
48,260 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-11-16 |
4 |
D |
$561.39 |
$3,990,360 |
D/D |
(7,108) |
53,764 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-12-10 |
4 |
AS |
$657.61 |
$4,745,202 |
D/D |
(7,122) |
59,167 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-11-16 |
4 |
AS |
$642.76 |
$4,638,263 |
D/D |
(7,167) |
55,705 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$6,559,828 |
D/D |
(7,657) |
48,306 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-01-27 |
4 |
AS |
$336.78 |
$2,727,279 |
D/D |
(8,000) |
49,951 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-13 |
4 |
AS |
$620.64 |
$5,028,022 |
D/D |
(8,000) |
41,951 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-12-09 |
4 |
D |
$657.11 |
$6,162,378 |
D/D |
(9,378) |
66,289 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-11-15 |
4 |
D |
$641.50 |
$6,037,798 |
D/D |
(9,412) |
62,872 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-02-14 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
68,470 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-05-16 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
68,470 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-08-15 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
68,470 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-11-14 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
67,110 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,214 |
57,350 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,625 |
57,951 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-13 |
4 |
OE |
$30.63 |
$398,190 |
D/D |
13,000 |
54,951 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-04 |
4 |
D |
$813.58 |
$10,954,041 |
D/D |
(13,464) |
65,957 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-11-13 |
4 |
D |
$795.69 |
$10,748,181 |
D/D |
(13,508) |
65,913 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-11-16 |
4 |
OE |
$30.63 |
$420,734 |
D/D |
13,736 |
60,872 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2024-03-13 |
4 |
D |
$971.82 |
$13,816,365 |
D/D |
(14,217) |
54,089 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-12-09 |
4 |
OE |
$52.03 |
$858,495 |
D/D |
16,500 |
75,667 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-11-15 |
4 |
OE |
$52.03 |
$862,605 |
D/D |
16,579 |
72,284 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-11-13 |
4 |
OE |
$270.43 |
$5,408,600 |
D/D |
20,000 |
79,421 |
0 |
- |
|
52 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
